Abstract
Probenecid retards the efflux of acid monoamine metabolites from the brain tissue and CSF to the blood. The probenecid-induced accumulation of these metabolites is held to be indicative of the turnover rate of the corresponding amines. Although the penetration of probenecid into the CSF does not proceed at a constant rate, Korf et al. (1972) and Sjöstrom (1972) have shown a correlation between CSF levels of probenecid and that of HVA and 5-HIAA. In this study an attempt was made to establish the relationship between doses of probenecid and levels of this compound in plasma and CSF; between levels in plasma and CSF; and between CSF levels of probenecid and of HVA and 5-HIAA. This study was performed in a homogeneous group of laboratory rabbits.
All correlations proved to be significant. The implications of these results for studies using the probenecid technique are discussed.
Similar content being viewed by others
References
Andén, N.-E., Magnusson, T.: An improved method for the fluorimetric determination of 5-hydroxytryptamine in tissues. Acta physiol. scand. 69, 89–94 (1967)
Andersson, H., Roos, B.-E.: 5-HIAA and HVA in CSF of different rabbit breeds after treatment with probenecid. J. Pharm. Pharmacol. 24, 165–166 (1972)
Andersson, H., Von Essen, C., Roos, B.-E.: On the elimination of 5-HIAA and HVA from CSF. Acta Pharmacol. (Kbh.) 32, 129–138 (1973a)
Andersson, H., Von Essen, C., Roos, B.-E.: 5-HIAA and HVA in CSF after intrathecal and intravenous administration of probenecid to normal and hydrocephalic dogs. Acta Pharmacol. (Kbh.) 32, 139–147 (1973b)
Barkai, A., Glusman, M., Rappaort, M. M.: Serotonin turnover in the intact cat brain. J. Pharmacol. exp. Ther. 181, 28–35 (1972)
Bowers, M. B., Jr.: 5-HIAA in the brain and CSF of the rabbit following administration of drugs affecting 5-HT. J. Neurochem. 17, 827–828 (1970)
Bowers, M. B., Jr.: CSF 5-HIAA and HVA following probenecid in unipolar depressives treated with amitriptyline. Psychopharmacologia (Berl.) 23, 26–33 (1972)
Bowers, M. B., Jr.: 5-HIAA and HVA following probenecid in acute psychotic patients treated with phenothiazines. Psychopharmacologia (Berl.) 28, 308–318 (1973)
Bowers, M. B., Jr., Gerbode, F.: CSF 5-HIAA: effects of probenecid and parachlorophenylalanine. Life Sci. 7, 773–776 (1968)
Brun, A., Gottfries, C. G., Roos, B.-E.: Studies of the monoamine metabolism in the central nervous system in Jacob-Creutzfeldt disease. Acta neurol. scand. 47, 642–645 (1971)
Dayton, P. G., Yu, T. F., Chen, W., Berger, L., West, L. A., Gutman, A. B.: The physiological disposition of probenecid, including renal clearance, in man, studies by an improved method for its estimation in biological material. J. Pharmacol. exp. Ther. 140, 278–286 (1963)
Eccleston, D.: A critical evaluation of techniques for studying synthesis and turnover of 5-HT in the brain in vivo. In: Pharmacology and the future of man. Proc. 5th Int. Congr. Pharmacology, San Francisco 1972, vol. 4, pp. 257–268. Basel: Karger 1973
Gottfries, C. G., KjÄllquist, å., Pontén, U., Roos, B.-E., SundbÄrg, G.: CSF pH and monoamine glucolytic metabolites in Alzheimer's disease. Brit. J. Psychiat. 124, 280–287 (1974)
Guldberg, H. C., Ashcroft, G. W., Crawford, T. B. B.: Concentrations of 5-hydroxyindoleacetic acid and homovanillic acid in the cerebrospinal fluid of the dog before and during treatment with probenecid. Life Sci. 5 1571–1575 (1966)
Korf, J., Van Praag, H. M.: Amine metabolism in human brain: further evaluation of the probenecid test. Brain Res. 35, 221–230 (1971a)
Korf, J., Ottema, S., Van der Veen, H. J.: Fluorimetric determination of homovanillic acid in biological material after isolation on Sephadex G10. Analyt. Biochem. 40, 187–191 (1971b)
Korf, J., Van Praag, H. M., Sebens, J. B.: The effect of intravenously administered probenecid in humans on the levels of 5-hydroxyindoleacetic acid, homovanillic acid and 3-methoxy-4-hydroxyphenylglycol in cerebrospinal fluid. Biochem. Pharmacol. 20, 657–668 (1971c)
Korf, J., Van Praag, H. M., Sebens, J. B.: Serum tryptophan decreased, brain tryptophan increased and brain serotonin synthesis unchanged after probenecid loading. Brain Res. 42, 239–242 (1972)
Lakke, J. P. W. F., Korf, J., Van Praag, H. M., Schut, T.: The predictive value of the probenecid test for the effect of levodopa therapy in Parkinson disease. Nature (Lond.) 236, 208–209 (1972)
Lal, S., De La Vega, C. E., Garelis, E., Sourkes, T. L.: Apomorphine, pimozide, l-dopa and the probenecid test in Huntington's Chorea. Psychiat. Neurol. Neurochir. (Amst.) 76, 113–117 (1973)
Muizelaar, J. P.: Neuronal firing in experimental hypercholesterolemia in the rabbit—a microiontophoretic study. Medical Thesis, Amsterdam 1974
Neff, N. H., Tozer, T. N., Brodie, B. B.: A specialized transport system to transfer 5-HIAA directly from brain to blood. Pharmacologist 6, 162 (1964)
Neff, N. H., Tozer, T. N., Brodie, B. B.: Application of steady-state kinetics to studies of the transfer of 5-hydroxyindoleacetic acid from brain to plasma. J. Pharmacol. exp. Ther. 158, 214–218 (1967)
Neff, N. H., Lin, R. C., Ngai, S. H., Costa, E.: Turnover rate measurements of brain serotonin in unanesthetized rats. In: Advances in biochemical psychopharmacology, vol. 1, E. Costa and P. Greengard, eds., pp. 92–109. New York: Raven Press 1969
Olsson, R., Roos, B.-E.: Concentrations of 5-hydroxyindoleacetic acid and homovanillic acid in the cerebrospinal fluid after treatment with probenecid in patients with Parkinson's disease. Nature (Lond.) 219, 502 (1968)
Van Praag, H. M., Korf, J.: Endogenous depressions with and without disturbances in the 5-HT metabolism: A biochemical classification? Psychopharmacologia (Berl.) 19, 148–152 (1971)
Van Praag, H. M., Korf, J.: 5-Hydroxytryptophan as an antidepressant: The predictive value of the probenecid test. J. nerv. ment. Dis. 158, 331–337 (1974)
Roos, B.-E., Sjöstrom, R.: 5-HIAA (and HVA) levels in the CSF after probenecid application in patients with manic-depressive psychosis. Pharmacol. Clin. 1, 153–155 (1969)
Sharman, D. F.: A discussion of the modes of action of drugs which increase the concentration of 4-hydroxy-3-methoxyphenylacetic acid (HVA) in the striatum of the mouse. Brit. J. Pharmacol. Chemother. 30, 620–626 (1967)
Sjöstrom, R.: Steady-state levels of probenecid and their relation to acid monoamine metabolites in human cerebrospinal fluid. Psychopharmacologia (Berl.) 25, 96–100 (1972)
Tamarkin, N. R., Goodwin, F. K., Axelrod, J.: Rapid elevation of biogenic amine metabolites in human CSF following probenecid. Life Sci. 9, 1397 (1970)
Watson, E., Wilk, S.: Determination of probenecid in small volumes of CSF. J. Neurochem. 21, 1569–1571 (1973)
Werdinius, B.: Effect of probenecid on the level of homovanillic acid in the corpus striatum. J. Pharmacol. exp. Ther. 18, 546–547 (1966)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Muizelaar, J.P., Oberink, J.I. Probenecid: Dosage, levels in plasma and cerebrospinal fluid (CSF) and influence upon CSF levels of homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA) in the rabbit. Psychopharmacologia 43, 223–227 (1975). https://doi.org/10.1007/BF00429254
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00429254